A novel RUNX1-C11orf41 fusion gene in a case of acute myeloid leukemia with a t(11;21)(p14;q22)

Cancer Genetics

Volumn 205, Issue 11, 2012, Pages 608-611

  Abe, Akihiro ^a   Katsumi, Akira ^b   Kobayashi, Miki ^b   Okamoto, Akinao ^a   Tokuda, Masutaka ^a   Kanie, Tadaharu ^a   Yamamoto, Yukiya ^a   Naoe, Tomoki ^c   Emi, Nobuhiko ^a  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

^c NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

AML; C11orf41; RUNX1; Translocation

Indexed keywords

CYTARABINE; DAUNORUBICIN; TRANSCRIPTION FACTOR RUNX1;

ACUTE GRANULOCYTIC LEUKEMIA; AGED; ARTICLE; BLEEDING; BLOOD TRANSFUSION; BONE MARROW EXAMINATION; CANCER GROWTH; CANCER PALLIATIVE THERAPY; CASE REPORT; CHROMOSOME TRANSLOCATION 11; CHROMOSOME TRANSLOCATION 21; DEATH; DYSPNEA; EXON; FATIGUE; FLUORESCENCE IN SITU HYBRIDIZATION; FUSION GENE; HUMAN; IMMUNOPHENOTYPING; INDUCTION CHEMOTHERAPY; INTRON; KARYOTYPE 46,XY; LEUKEMIA CELL; LEUKEMIA REMISSION; LEUKOCYTE COUNT; LOW DRUG DOSE; MALE; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; RANDOM AMPLIFIED POLYMORPHIC DNA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RUNX1 C11ORF41 GENE;

ABNORMAL KARYOTYPE; AGED; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 21; CORE BINDING FACTOR ALPHA 2 SUBUNIT; GENE REARRANGEMENT; HISTOCYTOCHEMISTRY; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA, MYELOID, ACUTE; MALE; ONCOGENE PROTEINS, FUSION; TRANSLOCATION, GENETIC;

EID: 84869460629     PISSN: 22107762     EISSN: 22107770     Source Type: Journal    
DOI: 10.1016/j.cancergen.2012.10.001     Document Type: Article

References (34)

1. Tenen D.G., Hromas R., Licht J.D., et al. Transcription factors, normal myeloid development, and leukemia. Blood 1997, 90:489-519.
2. Okuda T., van Deursen J., Hiebert S.W., et al. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell 1996, 84:321-330.
3. Kurokawa M. AML1/Runx1 as a versatile regulator of hematopoiesis: regulation of its function and a role in adult hematopoiesis. Int J Hematol 2006, 84:136-142.
4. Osato M., Asou N., Abdalla E., et al. Biallelic and heterozygous point mutations in the runt domain of the AML1/PEBP2alphaB gene associated with myeloblastic leukemias. Blood 1999, 93:1817-1824.
5. Song W.J., Sullivan M.G., Legare R.D., et al. Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia. Nat Genet 1999, 23:166-175.
6. Moosavi S.A., Sanchez J., Adeyinka A. Marker chromosomes are a significant mechanism of high-level RUNX1 gene amplification in hematologic malignancies. Cancer Genet Cytogenet 2009, 189:24-28.
7. De Braekeleer E., Ferec C., De Braekeleer M. RUNX1 translocations in malignant hemopathies. Anticancer Res 2009, 29:1031-1037.
8. Erickson P., Gao J., Chang K.S., et al. Identification of breakpoints in t(8;21) acute myelogenous leukemia and isolation of a fusion transcript, AML1/ETO, with similarity to Drosophila segmentation gene, runt. Blood 1992, 80:1825-1831.
9. Miyoshi H., Kozu T., Shimizu K., et al. The t(8;21) translocation in acute myeloid leukemia results in production of an AML1-MTG8 fusion transcript. EMBO J 1993, 12:2715-2721.
10. Andrieu V., Radford-Weiss I., Troussard X., et al. Molecular detection of t(8;21)/AML1-ETO in AML M1/M2: correlation with cytogenetics, morphology and immunophenotype. Br J Haematol 1996, 92:855-865.
11. Imagama S., Abe A., Suzuki M., et al. LRP16 is fused to RUNX1 in monocytic leukemia cell line with t(11;21)(q13;q22). Eur J Haematol 2007, 79:25-31.
12. Chinen Y., Taki T., Nishida K., et al. Identification of the novel AML1 fusion partner gene, LAF4, a fusion partner of MLL, in childhood T-cell acute lymphoblastic leukemia with t(2;21)(q11;q22) by bubble PCR method for cDNA. Oncogene 2008, 27:2249-2256.
13. Dai H.P., Xue Y.Q., Zhou J.W., et al. LPXN, a member of the paxillin superfamily, is fused to RUNX1 in an acute myeloid leukemia patient with a t(11;21)(q12;q22) translocation. Genes Chromosomes Cancer 2009, 48:1027-1136.
14. Guastadisegni M.C., Lonoce A., Impera L., et al. CBFA2T2 and C20orf112: two novel fusion partners of RUNX1 in acute myeloid leukemia. Leukemia 2010, 24:1516-1519.
15. Giguere A., Hebert J. CLCA2, a novel RUNX1 partner gene in a therapy-related leukemia with t(1;21)(p22;q22). Cancer Genet Cytogenet 2010, 202:94-100.
16. Grossmann V., Kohlmann A., Klein H.U., et al. Targeted next-generation sequencing detects point mutations, insertions, deletions and balanced chromosomal rearrangements as well as identifies novel leukemia-specific fusion genes in a single procedure. Leukemia 2011, 25:671-680.
17. Vardiman J.W., Thiele J., Arber D.A., et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 2009, 114:937-951.
18. ISCN 2009: International System of Human Cytogenetic Nomenclature 2009, Karger, Basel. L. Schaffer, M. Slovak, L. Campbell (Eds.).
19. Kuno Y., Abe A., Emi N., et al. Constitutive kinase activation of the TEL-Syk fusion gene in myelodysplastic syndrome with t(9;12)(q22;p12). Blood 2001, 97:1050-1055.
20. Yanada M., Terakura S., Yokozawa T., et al. Multiplex real-time RT-PCR for prospective evaluation of WT1 and fusion gene transcripts in newly diagnosed de novo acute myeloid leukemia. Leuk Lymphoma 2004, 45:1803-1808.
21. Mauritzson N., Albin M., Rylander L., et al. Pooled analysis of clinical and cytogenetic features in treatment-related and de novo adult acute myeloid leukemia and myelodysplastic syndromes based on a consecutive series of 761 patients analyzed 1976-1993 and on 5098 unselected cases reported in the literature 1974-2001. Leukemia 2002, 16:2366-2378.
22. Arber D.A., Slovak M.L., Popplewell L., et al. Therapy-related acute myeloid leukemia/myelodysplasia with balanced 21q22 translocations. Am J Clin Pathol 2002, 117:306-313.
23. Hromas R., Busse T., Carroll A., et al. Fusion AML1 transcript in a radiation-associated leukemia results in a truncated inhibitory AML1 protein. Blood 2001, 97:2168-2170.
24. Mikhail F.M., Coignet L., Hatem N., et al. A novel gene, FGA7, is fused to RUNX1/AML1 in a t(4;21)(q28;q22) in a patient with T-cell acute lymphoblastic leukemia. Genes Chromosomes Cancer 2004, 39:110-118.
25. Sakai I., Tamura T., Narumi H., et al. Novel RUNX1-PRDM16 fusion transcripts in a patient with acute myeloid leukemia showing t(1;21)(p36;q22). Genes Chromosomes Cancer 2005, 44:265-270.
26. Nguyen T.T., Ma L.N., Slovak M.L., et al. Identification of novel Runx1 (AML1) translocation partner genes SH3D19, YTHDf2, and ZNF687 in acute myeloid leukemia. Genes Chromosomes Cancer 2006, 45:918-932.
27. Asou N., Yanagida M., Huang L., et al. Concurrent transcriptional deregulation of AML1/RUNX1 and GATA factors by the AML1-TRPS1 chimeric gene in t(8;21)(q24;q22) acute myeloid leukemia. Blood 2007, 109:4023-4027.
28. Gawin B., Niederfuhr A., Schumacher N., et al. A 7.5 Mb sequence-ready PAC contig and gene expression map of human chromosome 11p13-p14.1. Genome Res 1999, 9:1074-1086.
29. The Human Protein Atlas. Available at Accessed 17.07.12. http://www.proteinatlas.org/.
30. Jones D.T., Kocialkowski S., Liu L., et al. Tandem duplication producing a novel oncogenic BRAF fusion gene defines the majority of pilocytic astrocytomas. Cancer Res 2008, 68:8673-8677.
31. Kelly L.M., Gilliland D.G. Genetics of myeloid leukemias. Annu Rev Genomics Hum Genet 2002, 3:179-198.
32. Frohling S., Scholl C., Gilliland D.G., et al. Genetics of myeloid malignancies: pathogenetic and clinical implications. J Clin Oncol 2005, 23:6285-6295.
33. Takahashi S. Current findings for recurring mutations in acute myeloid leukemia. J Hematol Oncol 2011, 4:36.
34. Tang J.L., Hou H.A., Chen C.Y., et al. AML1/RUNX1 mutations in 470 adult patients with de novo acute myeloid leukemia: prognostic implication and interaction with other gene alterations. Blood 2009, 114:5352-5361.